β-NADH , 98% , 606-68-8

Synonym(s):
NADH;β-NADH;β-DPNH;DPNH;Diphosphopyridine nucleotide reduced

CAS NO.：606-68-8

Empirical Formula: C21H30N7NaO14P2

Molecular Weight: 689.44

MDL number: MFCD00036200

EINECS: 210-123-3

PRODUCT Properties

• Melting point: 140-142°C
• Density: 1.955 at 20℃
• vapor pressure: 0.73Pa at 20-50℃
• storage temp.: Inert atmosphere,Store in freezer, under -20°C
• solubility: H₂O: 50 mg/mL, clear to nearly clear, yellow
• form: Powder
• color: Yellow
• PH: 7.5 (100mg/mL in water, ±0.5)
• Water Solubility: soluble
• BRN: 5230241
• Stability: Stable. Incompatible with strong oxidizing agents.
• InChIKey: QRGNQKGQENGQSE-WUEGHLCSSA-L
• LogP: -1.96 at 21℃ and pH7
• Surface tension: 69.22mN/m at 1.022g/L and 20℃

Description and Uses

β-Nicotinamide adenine dinucleotide (NAD+) and β-Nicotinamide adenine dinucleotide, reduced (NADH) comprise a coenzyme redox pair (NAD+:NADH) involved in a wide range of enzyme catalyzed oxidation reduction reactions. In addition to its redox function, NAD+/NADH is a donor of ADP-ribose units in ADP-ribosylaton (ADP-ribosyltransferases; poly(ADP-ribose) polymerases ) reactions and a precursor of cyclic ADP-ribose (ADP-ribosyl cyclases).

One of the biologically active forms of nicotinic acid. Serves as a coenzyme of hydrogenases and dehydrogenases. NAD usually acts as a hydrogen acceptor, forming NADH which then serves as a hydrogen donor in the respiratory chain. Present in living cells primarily in the reduced form (NADPH) and is involved in synthetic reactions. Occurs in 2 forms, α-NAD and β-NAD, distinguished by the configuration of the ribosyl nicotinamide linkage. Only the β-anomer is bioactive.

Safety

• Symbol(GHS): GHS07
• Signal word: Warning
• Hazard statements: H302-H315-H319-H335
• Precautionary statements: P261-P305+P351+P338
• Hazard Codes: Xn
• Risk Statements: 23/24/25-36/37/38-39/23/24/25-40-22
• Safety Statements: 26-36/37/39-45-24/25-36/37
• WGK Germany: 3
• F: 3-10-23
• TSCA: Yes
• HS Code: 29349990